NEXGEN COMPLETE KNEE SOLUTION ROTATING HINGE KNEE TIBIAL BROACH INPACTOR 의 리콜

Health Canada (via FOI)에 따르면, 해당 리콜 는 Canada 에서 ZIMMER BIOMET CANADA INC. 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

의료기기에 문제가 생겼을 경우 제조사가 이를 바로잡거나 시장에서 회수하는 조치를 말한다. 회수(Recall)는 의료기기에 결함이 있거나, 건강에 위협이 되거나, 또는 결함도 있고 건강에도 위협이 될 경우에 발생한다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Recall
  • 사례 ID
    48447
  • 사례 위험등급
    II
  • 사례 시작날짜
    2010-04-17
  • 사례 국가
  • 사례 출처
    HC
  • 비고 / 경고
    Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
  • 데이터 추가 비고
  • 원인
    There is a potential for the thumb pin detaching from these two instruments (nexgen complete knee solution stemmed tibial and rotating hinge knee tibial broach impactors) during impact. this presents the possibility of the thumb pin being left in the surgical site. the thumb pin is secured by epoxy and as the instrument ages the epoxy bond may fail allowing the pin to detach from the instrument.

Device

  • 모델명 / 제조번호(시리얼번호)
    Model Catalog: 00-5881-080-00 (Lot serial: 79006000); Model Catalog: 00-5881-080-00 (Lot serial: 60777631); Model Catalog: 00-5881-080-00 (Lot serial: 60067099); Model Catalog: 00-5881-080-00 (Lot serial: 50088600); Model Catalog: 00-5881-080-00 (Lot serial: 60009328); Model Catalog: 00-5881-080-00 (Lot serial: 52153800); Model Catalog: 00-5881-080-00 (Lot serial: 60040337); Model Catalog: 00-5977-011-00 (Lot serial: >10 NUMBERS CONTACT MFR)
  • 제품 설명
    NEXGEN COMP KNEE ROTATING HINGE KNEE
  • Manufacturer

Manufacturer

  • 제조사 주소
    MISSISSAUGA
  • 제조사 모회사 (2017)
  • 제조사 의견
    “The safety of patients has always been, and continues to be, Zimmer Biomet’s top priority and it is our honor to be a leader in this industry for the past 90 years,” Zimmer Biomet told ICIJ in a statement. “We adhere to strict regulatory standards, and work closely with the FDA and all applicable regulatory agencies in each of our regions as part of our commitment to operating a first-rate quality management system across our global manufacturing network. The company added that it is focused on staying at the forefront of innovation and doing right by the millions of patients who rely on the company’s products.
  • Source
    HC